In this presentation, OrganaBio’s CEO, Justin Irizarry, gives an overview of OrganaBio’s capabilities and how they can be leveraged to support the development and commercialization of cutting-edge cell and gene therapies. This talk was originally given at the 2021 Cell and Gene Meeting on the Mediterranean global conference. The conference brought together over 500 members of the cell and gene therapy community in an effort to stimulate collaborations and partnerships that accelerate the development of life-saving or life-altering therapies for patients in need.
The OrganaBio Blog
The Supply Brain
Addressing supply chain challenges in cell and gene therapy